HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ

The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiative that could allow the Trump administration to impose restrictions on its use, The Wall Street Journal reports.

By FiercePharma · Jun 8, 2026 · via FiercePharma
As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ

Image: FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma →

Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
Roche bets $700M upfront on Nurix's late-phase BTK degrader to tee up Lilly showdown
The WeekFierceBiotech ↗
Roche bets $700M upfront on Nurix's late-phase BTK degrader to tee up Lilly showdown
Roche is paying Nurix Therapeutics $700 million upfront for rights to bexobrutideg, securing a stake in a BTK …
Jun 8, 2026
Medicare Advantage Expansion Slows but Deepens in 2026
The WeekBriefing
Medicare Advantage Expansion Slows but Deepens in 2026
Over half of eligible Medicare beneficiaries are now in Medicare Advantage, with growth concentrated in specia…
Jun 8, 2026
Precision under pressure: Logistic solutions for nuclear medicine scalability
The WeekBioPharma Dive ↗
Precision under pressure: Logistic solutions for nuclear medicine scalability
Racing the clock: How precision logistics deliver life-saving nuclear medicine.…
Jun 8, 2026